S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS

• C. Kockerols,
• S. Dulucq,
• S. Bernardi,
• M. Farina,
• I. Civettini,
• G. Colafigli,
• S. Mori,
• P. Valk,
• F.-X. Mahon,
• C. Gambacorti-Passerini,
• F.-E. Nicolini,
• M. Breccia,
• D. Russo,
• P. E. Westerweel

Affiliations

C. Kockerols

1 Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands

S. Dulucq

2 Laboratory of Hematology, Hôpital Haut Lévêque, University hospital of Bordeaux,, Pessac, France

S. Bernardi

3 Clinical and Experimental Sciences, Hematology

M. Farina

3 Clinical and Experimental Sciences, Hematology

I. Civettini

4 University of Milano Bicocca, Monza

G. Colafigli

5 Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome

S. Mori

6 University of Milano-Bicocca, Monza, Italy

P. Valk

7 Molecular Biology, Erasmus University Medical Center, Rotterdam, Netherlands

F.-X. Mahon

8 Hematology, Institut Bergonié, Bordeaux, France

C. Gambacorti-Passerini

2 and Bone Marrow Transplant Center, University of Brescia, ASST Spedali Civili of Brescia, Brescia

F.-E. Nicolini

10 Hematology, Centre Léon Bérard and CRCL, Lyon, France

M. Breccia

5 Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome

D. Russo

3 Clinical and Experimental Sciences, Hematology

P. E. Westerweel

1 Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands